Oncora Medical, a radiation oncology software company, and the University of Texas MD Anderson Cancer Center are partnering to combine tools for collection and prediction of oncology outcomes to enable precision radiation oncology.

"Through this alliance, we hope to improve workflows and processes for radiation oncologists and simultaneously give radiation oncologists access to better information to support real-time, precision medical decision making,” said Benjamin Smith, MD, associate professor of radiation oncology, in a statement.

In the first phase, oncologists and IT professionals from MD Anderson will work with Oncora’s team of data scientists and engineers to install Oncora’s Precision Radiation Oncology Platform. This will be a software system that will assist radiation oncologists in the development of personalized treatment plans based on outcome predictions.

Oncora’s platform will be driven by data from MD Anderson’s electronic medical record system, tumor registry, radiation therapy planning system and Brocade, a web-based clinical documentation tool.

"This partnership provides an opportunity for precision medicine to truly improve the way cancer treatments are designed and delivered," said Oncora Medical co-founder and CEO, David Lindsay.